+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 4 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating GB-0895 as an add-on therapy for adolescents and adults with severe asthma that remains uncontrolled despite using inhaled corticosteroids and other asthma controllers. This global, multicenter, randomized, double-blind, placebo-controlled Phase 3 study aims to assess the effectiveness and safety of GB-0895 in improving asthma outcomes. Participants will receive either GB-0895 or a placebo through subcutaneous injections every six months during the treatment period. The study includes a screening and run-in phase from weeks -5 to 0, a treatment phase lasting 52 weeks, and a follow-up phase lasting from week 52 to week 90. An optional open-label extension allows continued GB-0895 treatment from week 52 through week 142. During the study, participants will undergo various assessments including lung function tests, questionnaires about asthma symptoms and quality of life, and monitoring for asthma exacerbations and adverse events. Researchers will measure outcomes such as the annual rate of asthma exacerbations and changes in lung function over 52 weeks. Safety evaluations will continue throughout treatment and follow-up. The total participation duration may extend up to nearly three years if the optional extension is chosen.

Age: 12Years - 80YearsAll GendersPhase 3
158 locations
S

Actively Recruiting

Researchers are studying a behavioral program aimed at reducing stigma related to HIV and drug use to help women living with HIV stay engaged in their HIV care. This trial focuses on women in Ukraine who use drugs and have been diagnosed with HIV. The study will evaluate how practical, acceptable, and effective the program is in improving HIV care engagement and medication adherence. Participants will be randomly assigned to one of two groups. Both groups will continue receiving standard HIV and substance use care and have a one-time consultation with a social worker. Those in the intervention group will also attend five small-group sessions over about 2 to 3 weeks that teach coping skills, communication, social support, and strategies to improve HIV care engagement. An optional individual session with a psychologist and a support person is also offered. All participants will complete assessments at the start, 3 months, and 6 months. During the study, participants will undergo evaluations including surveys and HIV care outcome assessments. Researchers will track how many women re-engage in HIV care and measure adherence to antiretroviral therapy over six months. The study will monitor stigma-related psychosocial outcomes to guide future research. Participation is expected to last approximately six months with scheduled assessments throughout this time.

Age: 18Years +FEMALEPhase Not Applicable
1 location
O

Actively Recruiting

This research aims to evaluate whether the group therapy method called I-Reconstruction can help reduce anxiety levels in adults. The study targets individuals with clinically significant anxiety and investigates if emotional stability improves after the therapy. Researchers will compare participants who attend the therapy sessions with those receiving usual care to determine if the new method offers more lasting benefits. The study involves three groups two experimental groups receiving the I-Reconstruction therapy and one control group continuing usual care without intervention. Participants in the therapy groups will attend ten weekly online group sessions, each lasting two hours, led by certified therapists. The therapy focuses on addressing preverbal trauma and internal conflicts related to desire, possession, and satisfaction through psychoeducation, emotional exploration, and group reflection. Participants will be involved in a 17-month process including screening, therapy sessions, and follow-up assessments at 3, 6, and 12 months after completing the therapy. They will complete questionnaires measuring anxiety, depression, internal conflicts, and preverbal dysregulation at multiple time points. The main outcomes include changes in anxiety levels assessed by the Beck Anxiety Inventory and Hospital Anxiety and Depression Scale. The control group will undergo the same assessments without receiving the therapy.

Age: 18Years - 55YearsAll GendersPhase Not Applicable
1 location
G

Actively Recruiting

This research aims to collect real-world data on patients with type 2 diabetes, hypertension, heart failure, and chronic kidney disease. It focuses on understanding patient characteristics, disease management, healthcare use, and outcomes across many countries. The study is an observational registry that includes patients seen in regular clinical practice worldwide. Participants are grouped based on their main condition or comorbidities, including type 2 diabetes, hypertension, chronic kidney disease, or heart failure. Data is collected both retrospectively and prospectively using a cloud-based electronic case report form accessible to investigators and a scientific committee. The registry is open to all physicians managing these conditions globally. Participants contribute information about their health status, treatments, and clinical measurements over time. Researchers gather demographic data, disease history, lab tests, imaging, medication use, healthcare visits, and outcomes such as hospitalizations and complications. The study measures many health indicators at baseline and averages over three years to understand care quality and disease progression. Participation can last until the study ends in 2030.

Age: 18Years +All Genders
76 locations